Leaflet ANIDULAFUNGINA TEVA 100mg powder for concentrate infusion solution

Indicated for: invasive candidiasis; fungal infections

Route of administration: infusion

Substance: anidulafungin (antifungal)

ATC: J02AX06 (Antiinfectives for systemic use | Antimycotics for systemic use | Other antimycotics for systemic use)

Anidulafungin is an antifungal medication used for the treatment of invasive fungal infections, such as invasive candidiasis and aspergillosis. It belongs to the echinocandin class and works by inhibiting the synthesis of beta-(1,3)-D-glucan, an essential component of the fungal cell wall. By disrupting the cell wall, anidulafungin causes fungal cell death.

Anidulafungin is administered intravenously, usually once daily, and the duration of treatment depends on the severity of the infection and the patient's response. It is primarily used in hospitalized patients, especially those with compromised immune systems.

Common side effects include nausea, diarrhea, headache, and injection site reactions. In rare cases, severe adverse reactions such as allergic reactions, hepatotoxicity, or electrolyte imbalances may occur.

Patients receiving anidulafungin should undergo regular monitoring for liver function and signs of adverse reactions. The medication is an effective and well-tolerated option for treating severe fungal infections, helping to reduce the mortality associated with these conditions.